The use of rituximab in myasthenia gravis and Lambert-Eaton myasthenic syndrome.
AIM: To assess the treatment effects of rituximab in a population of patients with myasthenia gravis and Lambert-Eaton myasthenic syndrome. METHODS: Data on all treated patients in the UK were collected from referring physicians, with full case ascertainment and follow-up. RESULTS: Since 2004, 10 p...
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Journal article |
| Language: | English |
| Published: |
2011
|